Table of Contents

2019-2024 Global Dog Vaccines Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Dog Vaccines Consumption 2014-2024
  • 2.1.2 Dog Vaccines Consumption CAGR by Region
• 2.2 Dog Vaccines Segment by Type
  • 2.2.1 Attenuated Live Vaccines
  • 2.2.2 Conjugate Vaccines
  • 2.2.3 Inactivated Vaccines
  • 2.2.4 Subunit Vaccines
  • 2.2.5 Toxoid Vaccines
  • 2.2.6 DNA Vaccines
  • 2.2.7 Recombinant Vaccines
• 2.3 Dog Vaccines Consumption by Type
  • 2.3.1 Global Dog Vaccines Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Dog Vaccines Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Dog Vaccines Sale Price by Type (2014-2019)
• 2.4 Dog Vaccines Segment by Application
  • 2.4.1 ＜6 Months
  • 2.4.2 ≥ Months
• 2.5 Dog Vaccines Consumption by Application
  • 2.5.1 Global Dog Vaccines Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Dog Vaccines Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Dog Vaccines Sale Price by Application (2014-2019)

3 Global Dog Vaccines by Players

• 3.1 Global Dog Vaccines Sales Market Share by Players
  • 3.1.1 Global Dog Vaccines Sales by Players (2017-2019)
  • 3.1.2 Global Dog Vaccines Sales Market Share by Players (2017-2019)
• 3.2 Global Dog Vaccines Revenue Market Share by Players
  • 3.2.1 Global Dog Vaccines Revenue by Players (2017-2019)
  • 3.2.2 Global Dog Vaccines Revenue Market Share by Players (2017-2019)
• 3.3 Global Dog Vaccines Sale Price by Players
• 3.4 Global Dog Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Dog Vaccines Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Dog Vaccines Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Dog Vaccines by Regions

• 4.1 Dog Vaccines by Regions
  • 4.1.1 Global Dog Vaccines Consumption by Regions
  • 4.1.2 Global Dog Vaccines Value by Regions
• 4.2 Americas Dog Vaccines Consumption Growth
• 4.3 APAC Dog Vaccines Consumption Growth
• 4.4 Europe Dog Vaccines Consumption Growth
• 4.5 Middle East & Africa Dog Vaccines Consumption Growth

5 Americas

• 5.1 Americas Dog Vaccines Consumption by Countries
  • 5.1.1 Americas Dog Vaccines Consumption by Countries (2014-2019)
  • 5.1.2 Americas Dog Vaccines Value by Countries (2014-2019)
• 5.2 Americas Dog Vaccines Consumption by Type
• 5.3 Americas Dog Vaccines Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Dog Vaccines Consumption by Countries
  • 6.1.1 APAC Dog Vaccines Consumption by Countries (2014-2019)
  • 6.1.2 APAC Dog Vaccines Value by Countries (2014-2019)
• 6.2 APAC Dog Vaccines Consumption by Type
• 6.3 APAC Dog Vaccines Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Dog Vaccines by Countries
  • 7.1.1 Europe Dog Vaccines Consumption by Countries (2014-2019)
  • 7.1.2 Europe Dog Vaccines Value by Countries (2014-2019)
• 7.2 Europe Dog Vaccines Consumption by Type
• 7.3 Europe Dog Vaccines Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Dog Vaccines by Countries
  • 8.1.1 Middle East & Africa Dog Vaccines Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Dog Vaccines Value by Countries (2014-2019)
• 8.2 Middle East & Africa Dog Vaccines Consumption by Type
• 8.3 Middle East & Africa Dog Vaccines Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Dog Vaccines Distributors
• 10.3 Dog Vaccines Customer

11 Global Dog Vaccines Market Forecast

• 11.1 Global Dog Vaccines Consumption Forecast (2019-2024)
• 11.2 Global Dog Vaccines Forecast by Regions
  • 11.2.1 Global Dog Vaccines Forecast by Regions (2019-2024)
  • 11.2.2 Global Dog Vaccines Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Dog Vaccines Forecast by Type
• 11.8 Global Dog Vaccines Forecast by Application

12 Key Players Analysis

• 12.1 Bayer Healthcare
  • 12.1.1 Company Details
  • 12.1.2 Dog Vaccines Product Offered
  • 12.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer Healthcare News
• 12.2 Vetoquinol S.A
  • 12.2.1 Company Details
  • 12.2.2 Dog Vaccines Product Offered
  • 12.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Vetoquinol S.A News
• 12.3 Boehringer Ingelheim
  • 12.3.1 Company Details
  • 12.3.2 Dog Vaccines Product Offered
  • 12.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Boehringer Ingelheim News
• 12.4 Ceva
  • 12.4.1 Company Details
  • 12.4.2 Dog Vaccines Product Offered
  • 12.4.3 Ceva Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Ceva News
• 12.5 Eli Lilly
  • 12.5.1 Company Details
  • 12.5.2 Dog Vaccines Product Offered
  • 12.5.3 Eli Lilly Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Eli Lilly News
• 12.6 Heska Co.
  • 12.6.1 Company Details
  • 12.6.2 Dog Vaccines Product Offered
  • 12.6.3 Heska Co. Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Heska Co. News
• 12.7 Merck Animal Health
  • 12.7.1 Company Details
  • 12.7.2 Dog Vaccines Product Offered
  • 12.7.3 Merck Animal Health Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Merck Animal Health News
• 12.8 Merial (Sanofi)
  • 12.8.1 Company Details
  • 12.8.2 Dog Vaccines Product Offered
  • 12.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Merial (Sanofi) News
• 12.9 Virbac
  • 12.9.1 Company Details
  • 12.9.2 Dog Vaccines Product Offered
  • 12.9.3 Virbac Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Virbac News
• 12.10 Zoetis (Pfizer)
  • 12.10.1 Company Details
  • 12.10.2 Dog Vaccines Product Offered
  • 12.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Zoetis (Pfizer) News

13 Research Findings and Conclusion

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs

According to this study, over the next five years the Dog Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dog Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Dog Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Dog Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
＜6 Months
≥ Months

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Dog Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Dog Vaccines market by identifying its various subsegments.
Focuses on the key global Dog Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dog Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dog Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.